Generic drug prices started creeping back up in October up after months of dropping throughout the pandemic , according to an analysis by the drug price watchdog 46Brooklyn. However, the price of dexamethasone, a steroid used to treat COVID-19 patients, leveled off in October. “We estimate that the price changes reported just this month translate to $81 million in annualized inflation on generic oral solid ingredient costs for Medicaid,” 46Brooklyn states. “Ordinarily we would highlight this as a large number,...